Treatment of skin disorders

Details Treatment of skin disorders Treatment of skin disorders

2006-05-16

2006-05-16

Weddington, Kevin E. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S266200, C514S863000

Reissue Patent

active

RE039096

ABSTRACT:
An effective treatment for skin disorders characterized by abnormal skin cell behavior, including a pharmaceutically effective amount of Halofuginone. Skin disorders which can be treated include keloids, hypertrophic scars, psoriasis, acne, seborrhea and alopecia. Halofuginone can reduce or eliminate clinical symptoms of these disorders, as well as substantially prevent the formation of keloids and hypertrophic scars.

REFERENCES:
patent: 5449678 (1995-09-01), Pines et al.
Knighton, et al, “Regulation of Cutaneous Wound Healing by Growth Factors and the Microenvironment”,Investigative Radiology, vol. 26, No. 6,pp. 604-611 (1991).
Haukipuro et al, “Synthesis of Typr I Collagen in Healing Wounds in Humans”,Ann of Surg., vol. 213, No. 1 pp. 75-80, (1991).
Granot et al, “Increased Skin Tearing in Broilers and Reduced Collagen Synthesis in Skin In Vivo and In Vitro In Response to the Coccidiostat Halofuginone”,Poultry Science, 70:1559-1563 (1991).
Ashcroft, The Effects of Ageing on Cutaneous Wound Healing in Mammals,J. Anat., vol. 187, pp. 1-26, (1995).
Choi et al, “Halofuginine, A Specific Collagen Type 1 Inhibitor, Reduces Anastomic Intimal Hyperplasia”Arch. Surg., vol. 130, pp. 257-261, (1995).
Freidman, et al “Regulation in Collagen Gene expression in Keloids and Hypertrophic Scars”,J. Surg. Res., 55:214-222 (1993).
Rockwell, et al, “Keloids and Hypertrophic Scars: A Comprehensive Review”,Plastic and Recon. Surg., vol. 84, No. 5, pp. 827-836, (1989).
Dauo-Brown, D.D., “Keloids: A Review of the Literature”,Brit. J. Plastic Surg., 43:70-77, (1990).
Nagler, et al, “Inhibition of Collagen Synthesis, Smooth Muscle Cell Proliferation, and Injury-Induced Intimal Hyperplasia by Halofuginone”,Arter., Thromb.&Vasc. Biol., vol. 17, No. 1, pp. 1-9 (1997).
Tulandi, T., “Prevention of Postoperative Intra-Abdominal Adhesions”,Curr. Opin. In Obst.&Gyn., 2:87-290,(1990).
Menzies, D., “Postoperative Adhesions: Their Treatment and relevance in Clinical Practice”, Ann. Roy. Col. Surg., vol. 75, 147-153, (1993).
Drolette, et al, “Pathophysiology of Pelvic Adhesions”,J. Reprod. Med., vol. 37, No. 2, pp. 107-122 (1992).
Monk et al, “Adhesions after Extensive Gyneclogic Surgery: Clinical Significance, Etiology and Prevention”,Am. J. Obstet.Gynecol,vol. 170, No. 5, Part 1, pp. 1396-1403 (1994).
Weinstein et al, “Cell Proliferation Kinetiks”, no further information.
Glinski et al, “Alteration of T-cell Extracellular Matrix Proteins interactions in Psiorasis”.
Holz et al, “Inhibition of Peritoneal Adhesion Reformation After Lysis with Thirty-Two Percent Dextran 70”,Fertility and Sterility, vol. 34, No. 4, pp. 394-395 (1980).
Menzics et al, “Intral-Abdominal Adhesions and Thei Prevention by Topical Tissue Plasminogen Activator”,J. Roy. Soc. Med., vol. 82 pp. 534-535 (1989).
Raftery, A.T., “Effect of Peritoneal Trauma on Peritoneal Fibrinolytic Activity and Intraperitoneal Adhesion Formation”,Eur. Surg. Res., 13:397-401 (1981).
Rivkind et al, “Urokinase Does Not Prevent Abdominal Adhesion Formation in Rats”,Eur. Surg. Res., 17:254-258 (1985).
Weibel et al, “Peritoneal Adhesions and their Relation to Abdominal Surgery”,Am. J. Of Surg., vol. 126, pp 345-353 (1973.
Gilmore et al “Prevention of Peritoneal Adhesions by a New Providone-Iodine/PVP Solution”, J. Of Surg. Res.,J. Of Surg. Res., vol. 25, pp. 477-481 (1978).
Rivkind et al, Cianidanol ([+]-Cianidanol-3) Prevents the Development of Abdominal Adhesions in Rats),Arch. Surg., vol. 118, pp. 1431-1433 (1983).
Menzies et al, “The Role Plasminogen Acrivator in Adhesion Prevention”,Surg. Gynecol.&Obstet., vol. 172, pp. 361-366 (1991).
Brooks et al “Integrin αvβ3Antagonists Promote Tumor Regression by Inducing Apoptosis of Angeogenic Blood Vessels”,Cell, vol. 79, pp. 1157-1164 (1994).
Folkman et al, “Angiogenesis”,J. Of Biological Che, vol. 267 No. 16 pp. 109031-109109 (1992).
Folkman et al, “Angiogenic Factors”,Science, vol. 235, pp. 442-447 (1987).
Folkman, J., “Toward an Understanding of Angiogensis: Search & Discovery”,Persp. In Biol.&Med., pp. 11-37 (1985).
Salo et al, “Effect of Phenytoin and Nifedipine on Collagen Gene expression in Human Gingival Fibroblasts”.
Nickoloff et al, “Abberant Production of Interleukin-8 and Thrombospondin-1 by Psoriatic Keratinocytes Mediates Angiogenesis”,Am. J. Path. vol. 144, No. 4, pp. 820-828 (1994).
Mahadevan et al, “The Effects of Ovarian Adhesive Disease Upon Follicular Development in Cycles of Controlled Stimulation for In Vitro Fertilization”, Fertility & Sterility, vol. 44, No. 4, pp. 489-492 (1985).
Takahashi et al, “Cellular Markers That Distingui the Phases of Hemangioma during Infancy and Childhood”,J. Clin. Invest., vol. 93, pp. 2357-2364 (1994).
Weidner et al, “Tumor Angiogenesis Correlates with Metastasis in Invasive Prostrate Carcinoma”,Am. J. Path., vol. 143, No. 2, pp. 401-409 (1993).
Folkman, J., “What is the Evidence That Tumors are Angiogenesis dependent?”, J. Nat'l. Cancer Inst., vol. 82, No. 1, pp. 4-6, (1989).
Peacock et al., “Angiogenesis Inhibition Suppresses Collagen Arthritis”,J. Exp. Med., vol. 175, pp. 1135-1138 (1992).
Miller et al, “Vascular Endothelial Growth factor/Vascular Permeability factor is tempoarilyand Spatially Correlated with Ocular Angiogenesis in a Primate Model”,Am. J. Path., vol. 145, No. 3, pp. 574-584 (1994).
Folkman, J., “Angiogenesis in Cancer, Vascular, Rheumatoid and Other Disease”,Nature Medicine, vol. 1, No. 1, pp. 27-31 (1995).
Bischoff, J. “Approaches to Studying Cell Adhesion Molecules in Angiogenesis”,Trends in Cell Biol., vol. 5, pp. 69-74 (1995).
Sawhney et al, “Optimization of Photopolymerized Bioerodable Hydrogel Properties for Adhesion Prevention”,J. Biomed. Mat. Res., vol. 28, pp. 831-838 (1994).
Jackson et al, “Type I Collagen Fibrils Promote Rapid Vascular Tube Formation Upon Contact with the Apical Side of Cultured Endothelium”,Exp. Cell Res., 192:319-323 (1991).
Iruela-Arispe et al, “Differential Expression of Extracellular Proteins is Correlated with Angiogenesis In Vitro”,Lab. Invest., vol. 64, No. 2, pp. 174-186 (1991).
Ingber et al, “Synthetic Analogues of Fumagillin that Inhibit Angiogenesis and Suppress Tumor Growth”,Nature, vol. 348, pp. 555-557 (1990).
Castle et al, “Antisense-Mediated Reduction in Thrombospondin Reverses the Mlignant Phenotype of a Human Squamous Carcinoma”,J. Cli. Invest., vol. 87, pp. 1883-1888 (1991).
Hill-West et al, “Efficacy of a Resorable Hydrogel Barrier, Oxidized Regenerated Cellulose, and Hyaluronic Acid in the Prevention of Ovarian Adhesions in a Rabbit Model”,Fertility&Sterility, vol. 62, No. 3, pp. 630-634 (1994).
Vick., “Statistics of Acute Intestinal Obstruction”Brit. Med. J., pp. 546-548 (1932).

Affiliated with

Also associated with

Rating

Treatment of skin disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of skin disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of skin disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3596401